ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $890 | +75.2% | 129,887 | +165.2% | 0.00% | – |
| Q2 2023 | $508 | +31.9% | 48,980 | +3.2% | 0.00% | – |
| Q1 2023 | $385 | -47.7% | 47,468 | +1.6% | 0.00% | – |
| Q4 2022 | $736 | -99.9% | 46,712 | -0.8% | 0.00% | – |
| Q3 2022 | $742,000 | +39.7% | 47,106 | +23.9% | 0.00% | – |
| Q2 2022 | $531,000 | -2.4% | 38,029 | +20.5% | 0.00% | – |
| Q1 2022 | $544,000 | +15.7% | 31,569 | -2.4% | 0.00% | – |
| Q4 2021 | $470,000 | -20.2% | 32,343 | -1.2% | 0.00% | – |
| Q3 2021 | $589,000 | -20.1% | 32,742 | -22.0% | 0.00% | – |
| Q2 2021 | $737,000 | +0.4% | 41,977 | +44.2% | 0.00% | – |
| Q1 2021 | $734,000 | +2058.8% | 29,120 | -7.2% | 0.00% | – |
| Q3 2019 | $34,000 | -50.0% | 31,393 | +0.5% | 0.00% | – |
| Q2 2019 | $68,000 | +7.9% | 31,246 | +199.1% | 0.00% | – |
| Q1 2019 | $63,000 | -99.3% | 10,446 | -96.9% | 0.00% | -100.0% |
| Q3 2017 | $8,784,000 | -20.6% | 340,343 | -16.5% | 0.00% | 0.0% |
| Q2 2017 | $11,058,000 | +7.7% | 407,743 | +18.4% | 0.00% | 0.0% |
| Q1 2017 | $10,268,000 | – | 344,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |